PL2875026T3 - Pochodne imidazopirydyny stosowane w leczeniu cukrzycy - Google Patents
Pochodne imidazopirydyny stosowane w leczeniu cukrzycyInfo
- Publication number
- PL2875026T3 PL2875026T3 PL13744752T PL13744752T PL2875026T3 PL 2875026 T3 PL2875026 T3 PL 2875026T3 PL 13744752 T PL13744752 T PL 13744752T PL 13744752 T PL13744752 T PL 13744752T PL 2875026 T3 PL2875026 T3 PL 2875026T3
- Authority
- PL
- Poland
- Prior art keywords
- diabetes
- treatment
- derivative used
- imidazopyridine derivative
- imidazopyridine
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 125000004857 imidazopyridinyl group Chemical class N1C(=NC2=C1C=CC=N2)* 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1257082A FR2993564B1 (fr) | 2012-07-20 | 2012-07-20 | Derives d'imidazopyridine utiles dans le traitement du diabete |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2875026T3 true PL2875026T3 (pl) | 2017-02-28 |
Family
ID=46785742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13744752T PL2875026T3 (pl) | 2012-07-20 | 2013-07-16 | Pochodne imidazopirydyny stosowane w leczeniu cukrzycy |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9381191B2 (pl) |
| EP (1) | EP2875026B1 (pl) |
| JP (1) | JP6154007B2 (pl) |
| KR (1) | KR102132744B1 (pl) |
| AU (1) | AU2013291866B2 (pl) |
| CA (1) | CA2879054C (pl) |
| DK (1) | DK2875026T3 (pl) |
| ES (1) | ES2602056T3 (pl) |
| FR (1) | FR2993564B1 (pl) |
| PL (1) | PL2875026T3 (pl) |
| PT (1) | PT2875026T (pl) |
| RU (1) | RU2648242C2 (pl) |
| WO (1) | WO2014013182A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020005489A2 (pt) | 2017-09-22 | 2020-09-24 | Jubilant Epipad Llc, | composto da fórmula (i), composto de fórmula (ii), composto de fórmula (iii), processo de preparação de compostos de fórmula (i), processo de preparação de compostos de fórmula (ii), processo de preparação de compostos de fórmula (iii), composição farmacêutica, método para inibir uma ou mais famílias pad em uma célula, método para tratar uma afeção mediada por um ou mais pads, utilização do composto, método para o tratamento e/ou prevenção de uma afeção mediada por um ou mais distúrbios da família pad, método para o tratamento de artrite reumatoide e método de tratamento de câncer |
| CN111225915B (zh) | 2017-10-18 | 2023-03-07 | 朱比兰特埃皮帕德有限公司 | 作为pad抑制剂的咪唑并吡啶化合物 |
| EP3707135A1 (en) | 2017-11-06 | 2020-09-16 | Jubilant Prodel LLC | Pyrimidine derivatives as inhibitors of pd1/pd-l1 activation |
| IL274762B2 (en) | 2017-11-24 | 2023-10-01 | Jubilant Episcribe Llc | Novel heterocyclic compounds as prmt5 inhibitors |
| EP3765453A1 (en) | 2018-03-13 | 2021-01-20 | Jubilant Prodel LLC | Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7612086B2 (en) * | 2003-05-16 | 2009-11-03 | Eisai R & D Management Co. Ltd. | JNK inhibitors |
| US20090176778A1 (en) | 2007-08-10 | 2009-07-09 | Franz Ulrich Schmitz | Certain nitrogen containing bicyclic chemical entities for treating viral infections |
| EP2072516A1 (en) * | 2007-12-21 | 2009-06-24 | Santhera Pharmaceuticals (Schweiz) AG | Substituted imidazopyridine derivates as Melancortin-4 receptor antagonists |
| FR2925905B1 (fr) * | 2008-01-02 | 2010-11-05 | Sanofi Aventis | DERIVES DE 2-BENZOYL-IMIDAZO°1,2-a!PYRIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
| EP2168965A1 (en) * | 2008-09-25 | 2010-03-31 | Santhera Pharmaceuticals (Schweiz) AG | Substituted imidazopyridine, imidazopyrazine, imidazopyridazine and imidazopyrimidine derivatives as melanocortin-4 receptor antagonists |
| PA8854101A1 (es) | 2008-12-18 | 2010-07-27 | Ortho Mcneil Janssen Pharm | Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa |
| WO2010089292A1 (en) | 2009-02-06 | 2010-08-12 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc | Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators |
-
2012
- 2012-07-20 FR FR1257082A patent/FR2993564B1/fr active Active
-
2013
- 2013-07-16 AU AU2013291866A patent/AU2013291866B2/en not_active Ceased
- 2013-07-16 PL PL13744752T patent/PL2875026T3/pl unknown
- 2013-07-16 JP JP2015522149A patent/JP6154007B2/ja not_active Expired - Fee Related
- 2013-07-16 PT PT137447520T patent/PT2875026T/pt unknown
- 2013-07-16 DK DK13744752.0T patent/DK2875026T3/en active
- 2013-07-16 RU RU2015101211A patent/RU2648242C2/ru active
- 2013-07-16 WO PCT/FR2013/051703 patent/WO2014013182A1/fr not_active Ceased
- 2013-07-16 CA CA2879054A patent/CA2879054C/fr active Active
- 2013-07-16 KR KR1020157004513A patent/KR102132744B1/ko active Active
- 2013-07-16 EP EP13744752.0A patent/EP2875026B1/fr active Active
- 2013-07-16 ES ES13744752.0T patent/ES2602056T3/es active Active
- 2013-07-16 US US14/415,985 patent/US9381191B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| FR2993564B1 (fr) | 2014-08-22 |
| EP2875026A1 (fr) | 2015-05-27 |
| CN104662020A (zh) | 2015-05-27 |
| KR102132744B1 (ko) | 2020-07-10 |
| EP2875026B1 (fr) | 2016-09-21 |
| DK2875026T3 (en) | 2017-01-09 |
| RU2015101211A (ru) | 2016-09-10 |
| US20150182507A1 (en) | 2015-07-02 |
| FR2993564A1 (fr) | 2014-01-24 |
| PT2875026T (pt) | 2016-12-13 |
| AU2013291866B2 (en) | 2017-08-10 |
| WO2014013182A1 (fr) | 2014-01-23 |
| JP2015522602A (ja) | 2015-08-06 |
| US9381191B2 (en) | 2016-07-05 |
| JP6154007B2 (ja) | 2017-06-28 |
| CA2879054A1 (fr) | 2014-01-23 |
| CA2879054C (fr) | 2021-02-09 |
| AU2013291866A1 (en) | 2015-02-26 |
| KR20150032910A (ko) | 2015-03-30 |
| RU2648242C2 (ru) | 2018-03-23 |
| ES2602056T3 (es) | 2017-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL275874A (en) | Therapeutic use of adenovirus | |
| IL263661A (en) | Combination therapy for the treatment of glioblastoma | |
| EP2867209A4 (en) | COMPOUNDS AND THEIR THERAPEUTIC USES | |
| EP2939625A4 (en) | THERAPEUTIC TREATMENT DEVICE | |
| IL238027A0 (en) | 2-phenyl-5-heterocyclyl-tetrahydro-h2-pyran-3-amine compounds for use in the treatment of diabetes and related disorders | |
| ZA201500229B (en) | Combinations of modalities for the treatment of diabetes | |
| EP2867239A4 (en) | OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF DIABETES | |
| SI2812013T1 (sl) | Formulacija za zdravljenje SRČ-ja | |
| AU348530S (en) | Wheelchair | |
| GB201201927D0 (en) | Wheelchair | |
| GB201218084D0 (en) | Novel compounds and methods for use in medicine | |
| GB201207305D0 (en) | Therapy | |
| EP2837326A4 (en) | MEDICAL APPARATUS | |
| PL2875026T3 (pl) | Pochodne imidazopirydyny stosowane w leczeniu cukrzycy | |
| EP2807980A4 (en) | MEDICAL TREATMENT DEVICE | |
| GB2515440B (en) | Vesicular Formulations for use in the treatment of Rosacea | |
| GB201205189D0 (en) | Novel medical use | |
| ZA201502153B (en) | Pyridinone compounds for use in photodynamic therapy | |
| LT2872176T (lt) | Karboranilporfirinai, skirti naudoti vėžio gydymui | |
| ZA201408065B (en) | Compositions and methods for the treatment of diabetes | |
| GB201215502D0 (en) | Medical use | |
| EP2804853A4 (en) | THERAPEUTIC USES | |
| GB201202094D0 (en) | Medical apparatus | |
| LT2863932T (lt) | Kompozicija, skirta naudoti limfedemos gydymui | |
| GB201211135D0 (en) | Treatment |